Caduet

Caduet, which is used to treat high blood pressure or chest pain for people with high cholesterol, had sales of $389 million for the year ending Sept. 30, according to IMS Health.

Mylan gets approval for generic Protonix | Pittsburgh Business Times 2011

Mylan also said Tuesday it will market a generic version of Pfizer's Caduet blood-pressure and high-cholesterol pill starting Nov. 30 under a settlement with the drug giant.

Mylan, Pfizer Settle on Lipitor Thomas Gryta 2011

Mylan may be able to sell a generic version of Caduet earlier under "certain circumstances" and said the settlement is also subject to Justice Department and FTC review.

Mylan, Pfizer Settle on Lipitor Thomas Gryta 2011

Economic Times Glaxo, Pfizer's patent claims turned down Indian authorities have rejected the patent applications of GlaxoSmithkline's anti-diabetic drug Avandia and Pfizer's cholesterol lowering drug Caduet, allowing other companies to sell generic versions of these drugs.

India News Digest: Lalu May Not Be Part of Next Government 2009

The application for Avandia (rosiglitazone) was refused because it failed to show any "enhanced efficacy over the existing compound", while that for Caduet was rejected as the patent office did not find any "inventive step".

India News Digest: Lalu May Not Be Part of Next Government 2009

In return for delaying its launch until November 2011, Ranbaxy secured the right to sell a copycat of Caduet -- another subject of litigation between the companies -- seven years before that drug's 2018 patent expiration.

Pfizer Buys More Time for Lipitor 2008

Caduet, a pill that combines Lipitor and the blood-pressure medicine Norvasc and had $568 million in 2007 sales, has been a disappointment for Pfizer.

Pfizer Buys More Time for Lipitor 2008

He added that the Caduet provision could draw FTC scrutiny.

Pfizer Buys More Time for Lipitor 2008

Cardiovascular drugs continued to pump revenue for the company during the fourth quarter: Norvasc saw another billion-dollar quarter and Caduet achieved 323% revenue growth worldwide for the quarter to $65 million.

McKinnell's Pfizer Faces Tough 2006 On Lipitor 2006

While visiting her mother in Pennsylvania this month, Lauren Pytel, a 47-year-old high school English teacher who lives in Tudor City, found herself pining for her cats, Tiggles ap Caduet and Munchie Effexorov, and their recently deceased siblings, Claritin and Zoloft.

NYT > Home Page By ANNA JANE GROSSMAN 2011